Viringa, UAB - company info and details

Company age: 22 y. 1 mo.

Update

Company overview

Company name Viringa, UAB
Company code 300055708
VAT code LT100002048513
Registered address Kauno r. sav., Neveronių sen., Neveronių k., Krašto g. 9, LT-54477
Registration date 2004-09-20 Company age: 22 y. 1 mo.
Phone Phone
Email Email
Website None
Company manager For registered members only Log in
Revenue (2025) 3,340 € +55% History
Profit (2025) 199 € History
Share capital 2,896 €
Number of employees 1 History
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity New construction
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Viringa, UAB (company code 300055708) is an operational private limited liability company registered in 2004. It is classified as a private entity in the sector of national private non-financial companies, with private ownership in which Lithuanian natural and legal persons hold more than 50% of the authorised capital and no foreign investor capital is included. Governance is described as CEO only. The company is a micro enterprise and is associated with the construction activity under EVRK code F.41.00.10, New construction.

The company is based in Neveroniu k., Neveroniu sen., Kauno r. sav., Kauno apskr., at Krašto g. 9. Its share capital is €2.9K. Financially, revenue increased from €1.6K in 2023 to €2.2K in 2024 and €3.3K in 2025, with growth of 54.9% year on year in the latest financial year and 106.2% over two years. The company reported a net profit of €199 in 2025 after losses in 2023 and 2024. Equity stood at €5.3K at the end of 2025, with total assets of €5.4K and liabilities of €46. The company employed 1 person on average in 2023, 2024 and 2025, and so far in 2026 the average employee count is also 1.

Download a detailed company report

Make confident decisions with all the information about Viringa, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report